Psychiatry and Neurology, Neurology · Oklahoma City, OK
NPI
1881896397
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
711 Stanton L Young Blvd, Suite 215
Oklahoma City, OK, 73104
Phone (405) 271-8001
Groups this clinician bills Medicare through
Medicare paid, 2024
$730K
103,388 services
Medicare patients, 2024
901
Average age 74
Drug cost, 2024
$12.6M
11,258 prescriptions
Company payments, 2025
$612K
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Cherian A Karunapuzha was code J0585 (injection, onabotulinumtoxina, 1 unit), 46,685 times for 99 patients. In total Cherian A Karunapuzha billed 103,388 services in 23 codes, and Medicare paid $730K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-11-10.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 46,685 | 99 | $4.89 | $228K |
| J0588 Injection, incobotulinumtoxin a, 1 unit | Office | 41,738 | 100 | $3.99 | $166K |
| J0587 Injection, rimabotulinumtoxinb, 100 units | Office | 11,068 | 59 | $10.08 | $112K |
| 99214 Office E&M - Established | Office | 1,187 | 820 | $86.43 | $103K |
| 64616 Musculoskeletal | Office | 378 | 145 | $126.68 | $48K |
| 64642 Musculoskeletal | Office | 328 | 147 | $57.87 | $19K |
| 64612 Musculoskeletal | Office | 174 | 61 | $103.61 | $18K |
| 64611 Musculoskeletal | Office | 113 | 65 | $60.42 | $6,828 |
| 64643 Musculoskeletal | Office | 98 | 44 | $66.23 | $6,490 |
| 95983 Electrical Nerve Conductivity | Office | 63 | 47 | $34.70 | $2,186 |
| 64646 Musculoskeletal | Office | 50 | 23 | $44.74 | $2,237 |
| 99213 Office E&M - Established | Office | 49 | 42 | $61.98 | $3,037 |
| 95984 Electrical Nerve Conductivity | Office | 46 | 19 | $30.32 | $1,395 |
| 64644 Musculoskeletal | Office | 28 | 11 | $101.45 | $2,841 |
| 99205 Office E&M - New | Office | 24 | 24 | $145.55 | $3,493 |
By year: 2022 $845K for 116,158 services; 2023 $813K for 115,052 services; 2024 $730K for 103,388 services.
Medicare prescription drug claims, 2024
In 2024, the drug Cherian A Karunapuzha prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 1,753 prescriptions and refills. In total Cherian A Karunapuzha wrote 11,258 Medicare prescriptions that cost $12.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 1,753 | 3,644 | 435 | $57K |
| Rytary Carbidopa/Levodopa | 877 | 1,288 | 160 | $1.2M |
| Amantadine Amantadine Hcl | 611 | 1,283 | 176 | $33K |
| Nuplazid Pimavanserin Tartrate | 539 | 563 | 71 | $2.8M |
| Donepezil Hcl Generic | 401 | 845 | 111 | $7,711 |
| Primidone Generic | 387 | 776 | 103 | $14K |
| Topiramate Generic | 374 | 825 | 97 | $6,462 |
| Clonazepam Generic | 369 | 372 | 62 | $2,970 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 304 | 657 | 79 | $8,444 |
| Gocovri Amantadine Hcl | 297 | 351 | 42 | $1.0M |
| Gabapentin Generic | 289 | 519 | 63 | $4,102 |
| Buspirone Hcl Generic | 262 | 434 | 67 | $3,374 |
| Propranolol Hcl Er Propranolol Hcl | 221 | 502 | 55 | $14K |
| Quetiapine Fumarate Generic | 202 | 351 | 56 | $2,372 |
| Nourianz Istradefylline | 199 | 233 | 31 | $450K |
Brand drugs: 2,911 claims; generic drugs: 8,347 claims; opioid claims: 75.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Cherian A Karunapuzha $612K ($612K in general payments such as food, travel and fees) from 19 companies. The largest payer was Teva Pharmaceuticals USA, Inc. with $193K.
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. TEVA | 90 | $193K |
| Neurocrine BioSciences, Inc. NBIX | 122 | $146K |
| MDD US Operations, LLC | 105 | $104K |
| ACADIA Pharmaceuticals Inc ACAD | 91 | $61K |
| Amneal Pharmaceuticals LLC AMRX | 58 | $54K |
| Abbvie Inc. ABBV | 58 | $53K |
| Merz Pharmaceuticals, LLC | 10 | $254 |
| Argenx US, Inc. ARGX | 3 | $174 |
| Medtronic, Inc. MDT | 1 | $174 |
| Harmony Biosciences LLC HRMY | 6 | $152 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.